Literature DB >> 25784994

Microelectrode array measurement of potassium ion channel remodeling on the field action potential duration in rapid atrial pacing rabbits model.

Juan Sun1, Huang Yan2, Najina Wugeti1, Yujun Guo1, Ling Zhang1, Mei Ma1, Xingui Guo2, Changan Jiao2, Wenli Xu2, Tianqi Li2.   

Abstract

BACKGROUND: Atrial fibrillation (AF) arises from abnormalities in atrial structure and electrical activity. Microelectrode arrays (MEA) is a real-time, nondestructive measurement of the resting and action potential signal, from myocardial cells, to the peripheral circuit of electrophysiological activity. This study examined the field action potential duration (fAPD) of the right atrial appendage (RAA) by MEA in rapid atrial pacing (RAP) in the right atrium of rabbits. In addition, this study also investigated the effect of potassium ion channel blockers on fAPD.
METHODS: 40 New Zealand white rabbits of either sex were randomly divided into 3 groups: 1) the control, 2) potassium ion channel blocker (TEA, 4-Ap and BaCl2), and 3) amiodarone groups. The hearts were quickly removed and right atrial appendage sectioned (slice thickness 500 μm). Each slice was perfused with Tyrode's solution and continuously stimulated for 30 minutes. Sections from the control group were superfused with Tyrode's solution for 10 minutes, while the blocker groups and amiodarone were both treated with their respective compounds for 10 minutes each. The fAPD of RAA and action field action potential morphology were measured using MEA.
RESULTS: In non-pace (control) groups, fAPD was 188.33 ± 18.29 ms after Tyrode's solution superfusion, and 173.91 ± 6.83 ms after RAP. In pace/potassium ion channel groups, TEA and BaCl2 superfusion prolonged atrial field action potential (fAPD) (control vs blocker: 176.67 ± 8.66 ms vs 196.11 ± 10.76 ms, 182.22 ± 12.87 ms vs 191.11 ± 13.09 ms with TEA and BaCl2 superfusion, respectively, P < 0.05). 4-AP superfusion significantly prolonged FAPD. In pace/amiodarone groups, 4-Ap superfusion extended fAPD.
CONCLUSIONS: MEA was a sensitive and stable reporter for the measurement of the tissue action potential in animal heart slices. After superfusing potassium ion channel blockers, fAPD was prolonged. These results suggest that Ito, IKur and IK1 remodel and mediate RAP-induced atrial electrical remodeling. Amiodarone alter potassium ion channel activity (Ito, IKur, IK1 and IKs), shortening fAPD.

Entities:  

Keywords:  Atrial fibrillation; field action potential duration; microelectrode arrays; potassium ion channel blocker; rapid atrial pacing

Year:  2015        PMID: 25784994      PMCID: PMC4358449     

Source DB:  PubMed          Journal:  Int J Clin Exp Med        ISSN: 1940-5901


  12 in total

1.  Ionic remodeling underlying action potential changes in a canine model of atrial fibrillation.

Authors:  L Yue; J Feng; R Gaspo; G R Li; Z Wang; S Nattel
Journal:  Circ Res       Date:  1997-10       Impact factor: 17.367

2.  Ion channel remodeling is related to intraoperative atrial effective refractory periods in patients with paroxysmal and persistent atrial fibrillation.

Authors:  B J Brundel; I C Van Gelder ; R H Henning; R G Tieleman; A E Tuinenburg; M Wietses; J G Grandjean; W H Van Gilst ; H J Crijns
Journal:  Circulation       Date:  2001-02-06       Impact factor: 29.690

3.  Ionic mechanisms of electrical remodeling in human atrial fibrillation.

Authors:  R F Bosch; X Zeng; J B Grammer; K Popovic; C Mewis; V Kühlkamp
Journal:  Cardiovasc Res       Date:  1999-10       Impact factor: 10.787

4.  Molecular mechanisms of early electrical remodeling: transcriptional downregulation of ion channel subunits reduces I(Ca,L) and I(to) in rapid atrial pacing in rabbits.

Authors:  Ralph F Bosch; Constanze R Scherer; Norman Rüb; Stefan Wöhrl; Klaus Steinmeyer; Hannelore Haase; Andreas E Busch; Ludger Seipel; Volker Kühlkamp
Journal:  J Am Coll Cardiol       Date:  2003-03-05       Impact factor: 24.094

5.  Molecular mechanisms underlying ionic remodeling in a dog model of atrial fibrillation.

Authors:  L Yue; P Melnyk; R Gaspo; Z Wang; S Nattel
Journal:  Circ Res       Date:  1999-04-16       Impact factor: 17.367

6.  Kv1.5 channelopathy due to KCNA5 loss-of-function mutation causes human atrial fibrillation.

Authors:  Timothy M Olson; Alexey E Alekseev; Xiaoke K Liu; Sungjo Park; Leonid V Zingman; Martin Bienengraeber; Srinivasan Sattiraju; Jeffrey D Ballew; Arshad Jahangir; Andre Terzic
Journal:  Hum Mol Genet       Date:  2006-06-13       Impact factor: 6.150

7.  Alterations in potassium channel gene expression in atria of patients with persistent and paroxysmal atrial fibrillation: differential regulation of protein and mRNA levels for K+ channels.

Authors:  B J Brundel; I C Van Gelder; R H Henning; A E Tuinenburg; M Wietses; J G Grandjean; A A Wilde; W H Van Gilst; H J Crijns
Journal:  J Am Coll Cardiol       Date:  2001-03-01       Impact factor: 24.094

8.  Electrical remodeling of the human atrium: similar effects in patients with chronic atrial fibrillation and atrial flutter.

Authors:  M R Franz; P L Karasik; C Li; J Moubarak; M Chavez
Journal:  J Am Coll Cardiol       Date:  1997-12       Impact factor: 24.094

9.  Identification, synthesis, and activity of novel blockers of the voltage-gated potassium channel Kv1.5.

Authors:  Stefan Peukert; Joachim Brendel; Bernard Pirard; Andrea Brüggemann; Peter Below; Heinz-Werner Kleemann; Horst Hemmerle; Wolfgang Schmidt
Journal:  J Med Chem       Date:  2003-02-13       Impact factor: 7.446

10.  Atrial fibrillation begets atrial fibrillation. A study in awake chronically instrumented goats.

Authors:  M C Wijffels; C J Kirchhof; R Dorland; M A Allessie
Journal:  Circulation       Date:  1995-10-01       Impact factor: 29.690

View more
  1 in total

1.  Growth differentiation factor-15 (GDF-15), novel biomarker for assessing atrial fibrosis in patients with atrial fibrillation and rheumatic heart disease.

Authors:  Yong-Ming Zhou; Ming-Jiang Li; Yan-Li Zhou; Le-Le Ma; Xin Yi
Journal:  Int J Clin Exp Med       Date:  2015-11-15
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.